Bio-Path Holdings Incorporated through its wholly-owned subsidiaries is engaged in the business of financing and facilitating the development of novel cancer therapeutics.


Updates from The Motley Fool

Latest updates on Bio-Path Holdings from Fool.com.


Stock Performance

BPTH vs. S&P 500 | 2 Year Performance
View Interactive BPTH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bio-Path Holdings.
Current Price: $1.73
Prev Close: $1.69
Open: $1.70
Bid: $1.55
Ask: $1.76
Day's Range: $1.69 - $1.75
52wk Range: $1.00 - $3.19
Volume: 414,471
Avg Vol 585,565
Market Cap: $155.29M
P/E (ttm): -28.17
EPS (ttm): -$0.06
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Bio-Path Holdings.
CAPS Rating 1 out of 5
 
5 Outperform
43 Underperform
CAPS All Stars
 
1 Outperform
37 Underperform

How do you think Bio-Path Holdings will perform against the market?



You pick for Bio-Path Holdings is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Bio-Path Holdings.

Bio-Path Holdings Incorporated through its wholly-owned subsidiaries is engaged in the business of financing and facilitating the development of novel cancer therapeutics.

  • Exchange: NASDAQ